US deal raises medicines spending and the NICE threshold in return for US tariff relief. Critics focus on opportunity-cost, ...
How is Trump’s Most Favoured Nation pricing reshaping global medicine access? OHE’s World Health Summit panel examines MFN’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results